At first, COVID-19 vaccines won't be marketed in the usual sense, because the government will be the main buyer.
A COVID vaccine from the pharmaceutical company has been shown to be highly promising.
To build public trust, Pfizer shared details of their trials: who was tested, the race and ethnicity of participants, how they were monitored, how to measure success and funding sources.
Pfizer hopes to run with its “little blue pill” as long as it can. That includes the time-honored strategy of launching its own generic.
Pfizer recently raised the list prices for more than 40 of its prescription medications, including the pain med Lyrica. It’s the second time this year Pfizer has boosted list prices. The increases come at a time of increased public and political scrutiny over drug prices. Is Big Pharma not feeling the heat? Click the above […]
The Pfizer-Allergan merger is out, but what about inversions across the board?
A change in U.S. tax laws has put a halt to the merger.
Companies sidestep taxes that support Medicare or Medicaid, then sell those programs drugs.